Navigation Links
Spectrum Pharmaceuticals Announces Presentation of SPI-1620 Data at the AACR-NCI-EORTC International Conference
Date:10/24/2007

of oncology drug candidates that meet critical health challenges for which there are few other treatment options. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease. For more information, please visit our website at http://www.spectrumpharm.com.

Forward-looking statement -- This press release may contain forward-looking statements regarding future events and the future performance of Spectrum Pharmaceuticals that involve risks and uncertainties that could cause actual results to differ materially. These statements include but are not limited to statements that relate to our business and its future, Spectrum's ability to identify, acquire, develop and commercialize its portfolio of drug candidates, the Company's promising pipeline, that SPI-1620 could have a broad range of applications for use with chemotherapy in the treatment of solid tumors, that we will begin enrolling patients in a Phase 1 open label, dose-escalation study shortly after we receive IRB approval, the safety and efficacy of SPI-1620 and any statements that relate to the intent, belief, plans or expectations of Spectrum or its management, or that are not a statement of historical fact. Risks that could cause actual results to differ include the possibility that our existing and new drug candidates, may not prove safe or effective, that results of pre-clinical animal studies do not necessarily predict the results of later-stage clinical trials, the possibility that our existing and new drug candidates may not receive approval from the FDA, and other regulatory agencies in a timely manner or at all, the possibility that our existing and new drug candidates, if approved, may not be more effective, safer or more cost efficient than compet
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
2. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
3. Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
4. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
10. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Dec. 16 Vivakor, Inc. (OTC ... Development agreement with Baker Consulting out of ... Kyouko Group, Inc. out of South Florida. ... Vivakor to assist with business development, financing ... reported acquisition strategy. Specifically, Baker Consulting is ...
(Date:12/16/2009)... Dec. 16 MAQUET Cardiovascular LLC, ... announced that it has signed a three-year ... industry,s leading supply contracting company, for MAQUET,s ... The VASOVIEW products assist healthcare providers in ... arteries using only small incisions. This allows ...
(Date:12/16/2009)... -- TechniScan, Inc. (OTC Bulletin Board: ... company engaged in the development and commercialization of ... that Joe Pepper, PhD, has been appointed to ... Chairman Ken Hungerford commented, "Joe has extensive experience ... GE OEC Medical and U-Systems, both of whom ...
Breaking Medicine Technology:Vivakor Signs Business Development Agreement With Baker Consulting 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Humans Can Develop Bat Like Echolocation 51093 1Humans Can Develop Bat Like Echolocation 51093 2China Medicine Receives Approval for a RMB 20 Million Loan 51088 1China Medicine Receives Approval for a RMB 20 Million Loan 51088 2March of Dimes Names Two New Trustees 51084 1March of Dimes Names Two New Trustees 51084 2
(Date:12/16/2009)... million screenings conducted through national AAD program ... One person dies from melanoma, the deadliest form ... is often successfully treated, if caught early. That,s ... free skin cancer screenings in their communities through ... Cancer Screening Program. The program recently reached a ...
(Date:12/16/2009)... SCHAFFHAUSEN, Switzerland, Dec. 16 Tyco International ... the nomination of Michael E. Daniels for election ... company,s Annual General Meeting on March 10, 2010. ... of the Global Technology Services group of International ... worldwide responsibility for IBM,s Global Services business operations ...
(Date:12/16/2009)... from around the world have visited Israel,s Dead Sea ... reputation that dates back over 2000 years, and legend ... introduction of two bath salt lines from SaltWorks ( ... Dead Sea salt in their own homes. ,, SaltWorks, ... and essential oils - but no artificial colors or ...
(Date:12/16/2009)... Sermo ( http://www.sermo.com ), the world,s ... results of a new Sermo Vitals Report titled ... The report examines physician dialog about diabetes over ... of a variety of topics, including the therapies ... and candid/verbatim comments on issues related to diabetes. ...
(Date:12/16/2009)... Dec. 16 Medizone International, Inc. (OTC ... Board of Directors and the Board of Medizone ... Medizone International Inc. holds a 50% interest, agreed ... venture and reconvey to Medizone International all global ... Medizone International,s Chairman, Edwin G. Marshall said, "Time ...
Breaking Medicine News(10 mins):Health News:Dermatologists Reach Skin Cancer Screening Milestone 2Health News:Dermatologists Reach Skin Cancer Screening Milestone 3Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 2Health News:Sermo Vitals Report(TM) Quantifies One Year of Physician Conversation About Diabetes 3Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2
... In his newest book, retired scientist Robert L. Peck discusses connections ... learn how ancient science was well aware of the effects of ... the mind." , ... Lebanon, CT (PRWEB) January 21, ...
... open access journal PLoS Medicine suggests that ... of cardiovascular disease, such as heart failure and stroke, ... greater efforts should be made to encourage elderly people ... as high blood cholesterol and high blood pressure, which ...
... (Nasdaq: EXPO ), today announced that it would ... ended January 2, 2009, immediately following the close of the ... host a corresponding conference call and live webcast at 4:30 ... Chairman and Chief Executive Officer, and Richard Schlenker, Chief Financial ...
... CNO ),today announced its Board of Directors ... value by preserving the value of certain tax,assets primarily ... of the Internal Revenue Code. Section 382 would ... change." The rights plan was adopted,to reduce the ...
... leader in,enterprise medical information technology systems for hospitals ... been awarded a five-year,HeartSuite(TM) VERICIS(R) cardiology contract with ... of four hospitals in the Greater,Tacoma, Washington area. ... Tacoma,General Heart Hospital on November 15, 2008. , ...
... risk, speedier recovery, researchers say , , TUESDAY, Jan. 20 ... treating ailing hearts with angioplasty may be through the ... reduces risk, bleeding, cost and patient recovery time when ... one million Americans undergo angioplasty to open blocked arteries. ...
Other Medicine News:Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 2Health News:Newly Released Book by Retired Scientist Links Self-Control of Hormones to Perfecting One's Life 3Health News:Impaired kidney function raises risk of heart problems in the elderly 2Health News:Exponent to Announce Fourth Quarter and Fiscal Year 2008 Results 2Health News:Conseco Adopts Stockholder Rights Plan 2Health News:Conseco Adopts Stockholder Rights Plan 3Health News:Conseco Adopts Stockholder Rights Plan 4Health News:Conseco Adopts Stockholder Rights Plan 5Health News:Emageon Signs Agreement with Integrated Health Network MultiCare 2Health News:Emageon Signs Agreement with Integrated Health Network MultiCare 3Health News:Angioplasty Via Wrist May Be Safer 2
9" X 14" Translucent plastic may be used with illuminated test cabinets or as a wall chart 20/100 to 20/10....
Wilbrandt-binkhorst irrigating cannula....
McIntyre-Binkhorst Cannula have a smooth blunt tip end opening....
Wire lid retractor may be clamped to surgical drape with suture or elastic band. Large pair....
Medicine Products: